Skip to main content
Epidemiology and Infection logoLink to Epidemiology and Infection
. 2018 Oct 8;147:e22. doi: 10.1017/S0950268818002741

Multilocus sequencing-based evolutionary analysis of 52 strains of Burkholderia pseudomallei in Hainan, China

Y Fang 1,2,3,*, Z Hu 1,*, H Chen 4, J Gu 5, H Hu 2,3, L Qu 2,3,, X Mao 1,
PMCID: PMC6518616  PMID: 30293543

Abstract

Previously, we reported a phylogenetic study of 98 Burkholderia pseudomallei clinical isolates from Hainan, China. Here, we update the B. pseudomallei strain library with 52 strains from newly identified cases dating from 2014 to 2017, analysed by multilocus sequence typing. Twenty-two sequence types (STs) were identified from the 52 cases, illustrating high genetic diversity; five of them (ST1480, ST1481, ST1482, ST1483 and ST1484) were novel. ST46, ST50 and ST58 predominated (34.6%) as was the case in the previous study (35.7%). An e-BURST map of the ST profiles of the two collections of isolates showed their genetic foundation to be largely unchanged. Neighbour-joining tree analysis was suggestive of a close phylogenetic relationship between the novel STs from this series and those first reported from Hainan (ST1105, ST1099, ST55 and ST1095). Moreover, the two novel STs (1481 and 1483) showed close similarity to ST58 which originated in Thailand indicating a close relationship between B. pseudomallei strains from both countries. The previously described allele profiles gmhD-36 and lepA-68 were found for the first time in our strain collections. Our study emphasises the importance of monitoring the epidemiological status and evolutionary trends of B. pseudomallei in China.

Key words: Burkholderia pseudomallei, e-BURST, multilocus sequence typing (MLST)


Burkholderia pseudomallei is a select agent (Tier 1) as classified by the US Centers for Disease Control and Prevention (CDC), which can infect both animals and humans and causes the disease melioidosis [1]. Melioidosis was generally thought to be endemic in Southeast Asia and Northern Australia but is now known to be distributed on a much wider scale [25]. Clinical manifestations of melioidosis vary greatly, from pneumonia to sepsis, with a high mortality rate of 40%, and a clinical relapse rate up to 20% [68]. Hainan is the main melioidosis-endemic area of China and covers an area of 33 210 km2 with a population of over 9 million residents [810].

Multilocus sequence typing (MLST) has been used for the molecular epidemiological study of B. pseudomallei since 2003, and MLST data have proved to be easy-to-use, unambiguous and readily comparable across laboratories [11]. To date, approximately 1453 sequence types (STs) of B. pseudomallei have been identified worldwide, and the number of new cases identified by MLST increases each year. We have adopted this methodology as a standard analysis strategy for all B. pseudomallei strains isolated from cases of melioidosis in Hainan and previously published a phylogenetic and epidemiological study on 98 such isolates (2002–2014) [11]. Here, we report further phylogenetic analysis of 52 strains from cases in the province typed by MLST in the last 3 years to examine their genetic stability over time.

Fifty-two B. pseudomallei strains were isolated from melioidosis cases between January 2014 and August 2017 in Hainan Island; two were first isolated from non-coastal cities (Baisha and Qiongzhong). Most isolates were recovered from blood (63.5%) and pus (34.6%), others were from sputum (3.8%) and urine samples (3.8%) (Table 1). Clinical samples were cultured on Columbia blood agar incubated at 37 °C for 2–3 days. B. pseudomallei identification was confirmed by the Vitek 2 Compact system (BioMerieux, Missouri, USA), and 16S rRNA PCR as previously described [11].

Table 1.

Properties of the 52 strains of B. pseudomallei strains studied

Strain Year STa Allele at the following locus Region of Chinab Source Manifestation
ace gltB gmhD lepA lipA narK ndh
BPC102 2014 1104 3 1 36 3 5 2 3 Haikou Blood Pneumonia
BPC103 2014 658 1 4 2 1 1 4 3 Haikou Blood Septicaemia
BPC104 2014 58 3 1 5 1 1 4 1 Sanya Sputum Septicaemia
BPC105 2014 1096 3 4 28 1 1 3 1 Changjiang Pus Pneumonia
BPC106 2014 46 3 1 2 1 1 3 3 Haikou Blood Pneumonia
BPC107 2014 58 3 1 5 1 1 4 1 Danzhou Urine Pneumonia
BPC108 2014 1105 1 4 2 3 5 4 1 Baisha Pus Pneumonia
BPC109 2014 177 1 1 4 3 1 3 1 Changjiang Blood Sepsis
BPC110 2014 1094 1 2 28 3 1 9 3 Danzhou Blood Parotid infection
BPC111 2014 58 3 1 5 1 1 4 1 Ledong Blood Sepsis
BPC112 2014 354 1 1 3 2 1 4 1 Haikou Blood Pneumonia
BPC113 2014 1480 3 3 2 1 1 3 3 Dongfang Blood Sepsis
BPC114 2015 1099 1 12 3 2 1 2 1 Haikou Blood Pneumonia
BPC115 2015 1095 1 12 3 2 1 2 3 Haikou Pus Pneumonia
BPC116 2015 1106 1 2 28 3 8 4 3 Wenchang Pus Sepsis
BPC137 2015 50 3 1 2 1 1 4 3 Dongfang Pus Pneumonia
BPC138 2015 58 3 1 5 1 1 4 1 Sanya Pus Pneumonia
BPC139 2015 658 1 4 2 1 1 4 3 Sanya Blood Pneumonia
BPC140 2015 1108 3 1 2 68 1 4 3 Sanya Blood Pneumonia
BPC141 2015 58 3 1 5 1 1 4 1 Sanya Sputum Sepsis
BPC142 2015 70 3 4 11 3 5 4 6 Sanya Blood Soft tissue infection
BPC143 2015 50 3 1 2 1 1 4 3 Sanya Pus Soft tissue infection
BPC144 2015 562 1 1 4 1 1 29 1 Sanya Pus Pneumonia
BPC145 2015 1481 3 1 5 1 5 4 1 Qionghai Pus Pneumonia
BPC156 2016 1482 3 4 2 3 5 4 6 Sanya Blood Pneumonia
BPC169 2016 1483 1 1 11 1 5 4 1 Qionghai Blood Pneumonia
BPC147 2016 50 3 1 2 1 1 4 3 Sanya Blood Pneumonia
BPC148 2016 50 3 1 2 1 1 4 3 Sanya Blood Sepsis
BPC149 2016 50 3 1 2 1 1 4 3 Qionghai Blood Pneumonia
BPC150 2016 366 3 1 2 3 8 4 3 Sanya Pus Pneumonia
BPC151 2016 306 1 2 3 1 1 2 1 Sanya Pus Pneumonia
BPC152 2016 1091 3 4 2 1 1 4 3 Sanya Blood Pneumonia
BPC153 2016 46 3 1 2 1 1 3 3 Sanya Blood Pneumonia
BPC154 2016 46 3 1 2 1 1 3 3 Ledong Blood Pneumonia
BPC155 2016 366 3 1 2 3 8 4 3 Sanya Blood Pneumonia
BPC157 2016 930 1 1 3 2 5 1 1 Sanya Blood Pneumonia
BPC158 2016 46 3 1 2 1 1 3 3 Ledong Blood Pulmonary abscess
BPC159 2016 930 1 1 3 2 5 1 1 Sanya Blood Pneumonia
BPC160 2016 1109 1 2 2 1 1 4 1 Qiongzhong Blood Pneumonia
BPC161 2016 658 1 4 2 1 1 4 3 Sanya Blood Pneumonia
BPC162 2016 658 1 4 2 1 1 4 3 Sanya Pus Pneumonia
BPC163 2016 50 3 1 2 1 1 4 3 Sanya Pus Pneumonia
BPC164 2016 50 3 1 2 1 1 4 3 Sanya Blood Pneumonia
BPC165 2016 211 3 1 3 1 1 4 1 Sanya Blood Pneumonia
BPC166 2016 1110 1 12 3 2 1 22 3 Ledong Pus Pneumonia
BPC167 2016 58 3 1 5 1 1 4 1 Sanya Blood Pneumonia
BPC168 2016 1111 3 4 11 4 1 4 1 Baoting Blood Soft tissue infection
BPC170 2017 1091 3 4 2 1 1 4 3 Ledong Pus Sepsis
BPC171 2017 55 3 1 3 3 1 4 1 Ledong Blood Pneumonia
BPC172 2017 46 3 1 2 1 1 3 3 Lingshui Pus Pneumonia
BPC173 2017 48 3 1 2 1 1 4 1 Lingshui Pus Neck abscess
BPC174 2017 1484 1 1 2 3 1 4 3 Lingshui Blood Sepsis
a

The numbers in bold represent the novel STs, the death cases are labelled with underscore.

b

The shaded regions represent the regions which were identified as isolation locations in Hainan Island.

For MLST, PCR amplification of seven housekeeping genes was performed as previously published [11]. The sequence data for each allele were trimmed to a determined length and defined as relative allele numbers according to the B. pseudomallei MLST database (https://pubmlst.org/bpseudomallei). STs were assigned and all strain numbers were deposited in the database.

Clinical characteristics and patient demographic data were analysed in Microsoft Excel 2016. The phylogenetic relationships of all strains were generated using e-BURST v3 and compared against all strains in the database with JAVA 8.0. The STs of 98 strains previously described from Hainan [11] were also analysed to show the relationship and mutational trend between the two groups of strains. The interactive tree of life (iTOL) v3 (https://pubmlst.org/bigsdb?db=pubmlst_bpseudomallei_isolates) was used to display phylogenetic relationships. This tool generates neighbour-joining trees from concatenated nucleotide sequences based on the pair-wise differences in the allelic profiles of strains [12].

The distribution of melioidosis cases across the 17 city areas of Hainan Island between the two surveys 2002–2014 (black) and 2014–2017 (red) is shown in Supplementary Fig. S1. The ages among the 52 more recent cases ranged from 1 to 79 years (median – 47 years); the majority were male (76.9%) and farmers (71.2%). Pneumonia (71.2%) and sepsis (13.5%) remained the major manifestations of melioidosis, with some cases presenting with abscesses (5.8%) and soft tissue infections (7.7%). Seven deaths occurred following pneumonia or sepsis, and old age (⩾58 years); two of the deaths were associated with novel STs (Table 1).

All 52 strains were resolved into 22 STs, five of which (ST1480, ST1481, ST1482, ST1483 and ST1484) were novel (Table 1). The dominant STs occurring in ⩾4 cases were ST50 (seven cases; 13.5%), ST58 (six; 11.5%), ST46 (five; 9.6%) and ST658 (four; 7.7%); these four STs accounted for 42.3% of all cases and the remainder were associated with ⩽3 cases. This distribution reflects that found in the first survey where the dominant STs were ST46 (13 cases; 13.2%), ST50 (11; 11.2%) and ST58 (11; 11.2%), accounting for 35.7% in all 98 strains of B. pseudomallei.

The pair-wise differences in the allelic profiles of the STs identified in both strain collections are shown in Fig. 1a and b with novel STs highlighted by red circles. The three dominant ST48, ST50 and ST46 were grouped into a single clonal complex (CC), and two novel ST1480 and ST1481 fell in the same CC (Fig. 1a) with other novel STs in individual CCs. ST1482 was phylogenetically related to ST70 which originated from Thailand. Figure 1b shows the evolutionary trends and phylogenetic relationships between STs identified in the two studies (from 2002 to 2017). Novel STs identified in each study period are highlighted in green (2002–2014) and red (2014–2017), respectively. Half of the cases were clustered into a single dominant CC, with ST50 as founder, and ST46 as sub-founder. Likewise three of the novel STs in the present study (ST1480, ST1481 and ST1484) and five novel STs from the first study (ST1345, ST1346, ST1347, ST1350 and ST1351) were grouped in the same CC (Fig. 1b). Furthermore, some novel STs originated from the same founders but generated different gene types: ST1484, ST1345 and ST1350 (founder: ST51), ST1480 and ST1346 (founder: ST46), ST1481 and ST1351 (founder: ST211) (Fig. 1b). Additionally, ST1482 and ST1483 were grouped in different CCs; ST1482 showed close linkage to both ST70 and ST541, both of which were first isolated from Thailand and ST1483 had a relatively close relationship with ST1349, an ST related to ST562, which was shared by Australian and Chinese strains of B. pseudomallei [10].

Fig. 1.

Fig. 1.

e-BURST analysis of the B. pseudomallei strains. (a) MLST data of 52 STs in this study. The primary founder (yellow), ST48, is positioned centrally in the cluster and subgroup founder (blue) is ST50. Strain groups are connected by dark lines and the five novel STs are highlighted by red circles. Dot diameter reflects the number of cases. (b) e-BURST of sequence types for combined 150 strains from both surveys. Novel STs highlighted by red circles and green circles, respectively. Dot diameter reflects the number of cases.

The neighbour-joining tree shows the phylogenetic relationship among the 22 STs identified in strains from this study (Fig. 2). The five novel STs were genetically close to ST1105, ST1099, ST55 and ST58, and ST1096 (all first isolated from China, except for ST58, which was first isolated from Thailand). The dominant allele profiles were mostly the same as previously found, except for ndh-3; allele ndh-1 predominated in the first strain collection. Some rare alleles were evident between the studies, such as gmhD-36 (ST1196) and lepA-68 (ST1108) (Supplementary Table S1).

Fig. 2.

Fig. 2.

Interactive tree of life (iTOL) of MLST data from the present study. Neighbour-joining trees from concatenated nucleotide sequences based on the pair-wise differences in the allelic profiles. Twenty-two STs (identified from 52 strains, five novel STs labelled with asterisks).

It is clear that B. pseudomallei is no longer restricted to tropical regions but is increasingly found in non-endemic areas [6]. Melioidosis is relatively uncommon in China but most reported human cases in the country are from the tropical Hainan island [810], and as in other countries, pneumonia remains the most common presentation of the disease [7].

MLST has been repeatedly shown to be a simple and shareable strategy for molecular epidemiological studies of B. pseudomallei in various regions [2, 11]. Previously, we published an MLST study of 98 B. pseudomallei strains from Hainan, and here we have characterised 52 recently isolated strains and identified five novel STs. An e-BURST map of the 150 strains from both collections showed a clonal cluster with ST50 (first identified in China) as the founder genotype and that the genetic structure had remained largely unchanged over the 16-year period. Neighbour-joining tree analysis also suggests that recently emergent novel STs are closely related to some of the historical STs first isolated from Hainan Island. The linkage of two of the novel STs (1481 and 1483) to ST58, originating from Thailand, which has a close interplay with China [13]. Hainan attracts millions of tourists per year, which likely increases the risk of spreading infection among wider populations. A few melioidosis cases related to a history of travel in Hainan have been recorded by local hospitals in recent years (unpublished observations). In addition, the communications and commerce activities between the countries may promote the interaction of B. pseudomallei with different genetic backgrounds, and possibly give rise to the evolution of new gene types [13, 14]. No correlation was found between STs and geographic location, isolation source and clinical outcome of the patients but further genomic analysis may reveal hitherto unrecognised relationships [15].

In conclusion, this study has confirmed the relative genetic stability of B. pseudomallei strains in Hainan over a 15-year period. With the exception of the appearance of some novel STs, the clonal populations have remained mostly conserved but further monitoring of population structures and evolutionary trends through cooperative research with other endemic areas in the region is warranted.

Acknowledgements

We are grateful to Dr Erin Price (the curator of the B. pseudomallei MLST database, Royal Darwin Hospital Campus, Australia) for useful suggestions during the analysis.

Conflict of interest

None.

Financial support

This work was supported by the National Natural Science Foundation of China (grant numbers 81772141 and 81471914).

Ethical standards

This study was approved by the Human Research Ethics Committee of the Third Military Medical University, which is a member of the Chongqing City Ethics Committees of China. All clinical cases were anonymised without personal information.

Supplementary material

For supplementary material accompanying this paper visit https://doi.org/10.1017/S0950268818002741.

S0950268818002741sup001.docx (329.6KB, docx)

click here to view supplementary material

References

  • 1.White NJ (2003) Melioidosis. The Lancet 361, 1715–1722. [DOI] [PubMed] [Google Scholar]
  • 2.Tellapragada C et al. (2016) Unravelling the molecular epidemiology and genetic diversity among Burkholderia pseudomallei isolates from South India using multi-locus sequence typing. PLoS ONE 11, e0168331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Sarovich DS et al. (2016) Phylogenomic analysis reveals an Asian origin for African Burkholderia pseudomallei and further supports melioidosis endemicity in Africa. mSphere 1, e00089-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Currie BJ and Kaestli M (2016) Epidemiology: a global picture of melioidosis. Nature 529, 290–291. [DOI] [PubMed] [Google Scholar]
  • 5.Doker TJ et al. (2015) Contact investigation of melioidosis cases reveals regional endemicity in Puerto Rico. Clinical Infectious Diseases 60, 243–250. [DOI] [PubMed] [Google Scholar]
  • 6.Limmathurotsakul D et al. (2016) Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nature Microbiology 1, 15008. [DOI] [PubMed] [Google Scholar]
  • 7.McLeod C et al. (2015) Clinical presentation and medical management of melioidosis in children: a 24-year prospective study in the Northern Territory of Australia and review of the literature. Clinical Infectious Diseases 60, 21–26. [DOI] [PubMed] [Google Scholar]
  • 8.Fang Y et al. (2015) Melioidosis in Hainan, China: a retrospective study. Transactions of the Royal Society of Tropical Medicine and Hygiene 109, 636–642. [DOI] [PubMed] [Google Scholar]
  • 9.Yang S et al. (1998) Prevalence of human melioidosis on Hainan Island in China. Microbiology and Immunology 42, 651–654. [DOI] [PubMed] [Google Scholar]
  • 10.Li L, Lu Z and Han O (1994) [Epidemiology of melioidosis in China]. Zhonghua Liu Xing Bing Xue Za Zhi 15, 292–295. [PubMed] [Google Scholar]
  • 11.Fang Y et al. (2016) Multilocus sequence typing of 102 Burkholderia pseudomallei strains isolated from China. Epidemiology and Infection 144, 1917–1923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Letunic I and Bork P (2016) Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees. Nucleic Acids Research 44, W242–W245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Chen H et al. (2015) Burkholderia pseudomallei sequence type 562 in China and Australia. Emerging Infectious Diseases 21, 166–168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Price EP et al. (2016) Unprecedented melioidosis cases in Northern Australia caused by an Asian Burkholderia pseudomallei strain identified by using large-scale comparative genomics. Applied and Environmental Microbiology 82, 954–963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Nandi T et al. (2010) A genomic survey of positive selection in Burkholderia pseudomallei provides insights into the evolution of accidental virulence. PLoS Pathogens 6, e1000845. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

For supplementary material accompanying this paper visit https://doi.org/10.1017/S0950268818002741.

S0950268818002741sup001.docx (329.6KB, docx)

click here to view supplementary material


Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES